Details for New Drug Application (NDA): 211965
NDA 211965 describes MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by B Braun Medical, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Pharmobedient, and is included in six NDAs. It is available from five suppliers. Additional details are available on the MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
Summary for 211965
| Tradename: | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | magnesium sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 211965
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 211965 | ANDA | Baxter Healthcare Corporation | 0338-1709 | 0338-1709-40 | 40 BAG in 1 CASE (0338-1709-40) / 100 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/100ML | ||||
| Approval Date: | Aug 11, 2020 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
